Atlas Trials

Hyperthermia Combined With Immune Checkpoint Inhibitor Therapy for Advanced Gastrointestinal Tumours

Clinical trial NCT06022692 · COMPLETED

Trial details

NCT number
NCT06022692
Sponsor
Pengyuan Liu
Status
COMPLETED
Phase
Phase 1, Phase 2
Study type
INTERVENTIONAL
Gastrointestinal Tumor
Start date
2020-06-01
Primary completion
2022-05-31
Enrollment
18

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.